Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Harvard Business School
Dow
McKesson
Express Scripts

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 103976

See Plans and Pricing

« Back to Dashboard

Summary for BLA: 103976
Tradename:XOLAIR
Applicant:Genentech
Ingredient:omalizumab
Patents:104
Approval Date:Jun 20, 2003
Suppliers: see list1
Pharmacology for BLA: 103976
Drug ClassAnti-IgE
Mechanism of ActionIgE-directed Antibody Interactions
Physiological EffectDecreased IgE Activity

US Patents for BLA: 103976

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial ATOPIX THERAPEUTICS LIMITED (London, GB) 2034-05-02 RX search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2033-03-11 RX search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial Knopp Biosciences LLC (Pittsburgh, PA) 2033-08-13 RX search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial AbbVie Inc. (North Chicago, IL) 2026-09-08 RX search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial CureVac AG (Tubingen, DE) 2032-02-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Harvard Business School
McKinsey
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.